| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/23/2006 | US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 02/23/2006 | US20060040986 Erythropoietin production accelerator |
| 02/23/2006 | US20060040933 Antiinflammatory agents |
| 02/23/2006 | US20060040931 Benzomorpholine derivatives |
| 02/23/2006 | US20060040851 Gag-peptide complex |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040266 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 02/23/2006 | US20060040265 Regulation of novel human asparagine-hydroxylases |
| 02/23/2006 | US20060039903 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | CA2592521A1 Modified vitamin k dependent polypeptides |
| 02/23/2006 | CA2567782A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1627876A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1626966A1 Benzofuran inhibitors of factor viia |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | EP1000161B1 Anticoagulant fusion protein anchored to cell membrane |
| 02/22/2006 | EP0766580B1 Compositions of prostacyclin, pge or a nitrovasodilator or combinations thereof for the treatment of diseases of the vascular system |
| 02/22/2006 | CN1738788A Substituted phenyl naphthalenes as estrogenic agents |
| 02/22/2006 | CN1738624A Method of treatment of myocardial infarction |
| 02/22/2006 | CN1738599A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/22/2006 | CN1737012A Recombinant targeted infuse protein for promoting thrombocytopoiesis and its preparation method |
| 02/22/2006 | CN1736981A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1736475A Troxerutin brain protein hydrolysate for injection and preparation process thereof |
| 02/22/2006 | CN1736469A Chinese medicine for treating apoplexy sequelae and preparation process thereof |
| 02/22/2006 | CN1736453A Modified Chinese proprietary medicine for promoting urination and stopping pain |
| 02/22/2006 | CN1736403A Dripping pills of blumea balsamifera and its preparation process |
| 02/22/2006 | CN1736384A Mixture of higher primary aliphatic alcohols with acetylsalicylic acid and pharmaceutical formulation |
| 02/22/2006 | CN1736371A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1242999C Benzo-isoselenazole derivatives and its use |
| 02/22/2006 | CN1242814C Protease inhibitor of Ornithotoctonus huwena |
| 02/22/2006 | CN1242810C Drug composition, its preparation method and use |
| 02/22/2006 | CN1242803C Small honey pills for treating thrombus disease and its preparing process |
| 02/22/2006 | CN1242789C Process for preparing Chinese medicine soft capsule for treating and preventing thrombotic obliterating disease |
| 02/22/2006 | CN1242782C Medicine for treating cerebral thrombus and its preparing process |
| 02/22/2006 | CN1242776C Worm nutritious health oral liquid and its preparing method |
| 02/21/2006 | US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety |
| 02/21/2006 | US7002018 Process for the preparation of amorphous form of torsemide |
| 02/21/2006 | US7001993 site-directed mutagenesis; high protease-inhibitory activity in absence of heparin |
| 02/21/2006 | US7001989 Conjugates comprising two active agents |
| 02/21/2006 | US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents |
| 02/21/2006 | US7001914 Compounds |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | US7001898 Treating conditions involving increased vascular resistance and cardiac insufficiency. |
| 02/21/2006 | US7001894 Blood flow improvers and thrombosis preventives or remedies |
| 02/21/2006 | US7001885 Isolation of biopolymers from human serum albumin; obtain human serum albumin, expose to ion exchange resin, elute and recover biopolymer |
| 02/16/2006 | WO2006016582A1 Liquid culture method for inonotus obliquns |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060035911 Method of improved diuresis in individuals with impaired renal function |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035847 e.g. 1,2-Dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; synergistic mixture with other active compounds |
| 02/16/2006 | US20060035840 Beta-D-Glucopyranosyloxy)-3-(3-fluoro-4-methylbenzyl)-4,6-dimethylpyridine; sodium glucose co-transporter 2 (SGLT2) inhibitors; excellent hypoglycemic effect by excreting excess glucose into the urine through preventing the reabsorption of glucose at the kidney; antidiabetic agents; hyperglycemia |
| 02/16/2006 | US20060035819 Novel molecule |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035299 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 02/16/2006 | US20060034951 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/16/2006 | US20060034799 Tissue protective cytokines for the protection, restoration, and enhancement fo responsive cells, tissues and organs |
| 02/16/2006 | US20060032400 Modified hydroxyethyl- or hydroxypropyl-substituted starch product for clinical use, which has a degree of branching of 8-10 mol %, a degree of substitution of up to 0.3, an average molecular weight of 10000- 450000; product is not derived from an amylopectin fraction |
| 02/16/2006 | DE102004034913A1 Neue Verbindungen, die Faktor Xa-Aktivität inhibieren Novel compounds which inhibit factor Xa activity |
| 02/16/2006 | DE102004032823A1 New D-xylopyranosyl-substituted phenyl compounds are sodium-dependent glucose cotransporter inhibitors useful to prevent or treat e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis |
| 02/15/2006 | EP1625847A1 Pharmaceutical composition comprising a tetrahydrotriazolo[4,3-a]pyrazine |
| 02/15/2006 | EP1625156A2 Peptides that bind to the erythropoietin receptor |
| 02/15/2006 | EP1625128A2 Thermal energy storage |
| 02/15/2006 | EP1624786A2 Methods for the treatment and prevention of diseases of biological conduits |
| 02/15/2006 | EP1341533B1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 02/15/2006 | EP0795021B1 Retroviral delivery of full length factor viii |
| 02/15/2006 | CN1735630A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 02/15/2006 | CN1735603A Benzomorpholine derivatives |
| 02/15/2006 | CN1735595A Substituted alkyl amido piperidines |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733298A Microcapsule type blood substitute based on hemoglobin and process for preparing the same |
| 02/15/2006 | CN1733269A Drop pill made from root rhizome and herb of common lamiophlomis and process for preparing the same |
| 02/15/2006 | CN1733189A Technique for preparing Yueju capsule and quality control method |
| 02/15/2006 | CN1733185A Capsule dragon's blood and process for preparing the same |
| 02/15/2006 | CN1733140A New preparation for curing diseases of qi deficiency and blood insufficiency |
| 02/15/2006 | CN1733139A Chinese traditional medicine preparation for nourishing yin and blood, its preparation process and quality control method |
| 02/15/2006 | CN1733136A Medicine for invigorating qi and nourishing blood comprising donkey-hid gelatin and angelica and process for preparing the same |
| 02/15/2006 | CN1733126A Chinese traditional medicine preparation for strengthening blood and process for preparing the same |
| 02/15/2006 | CN1733100A Chinese medicinal preparation for strengthening bone and generating blood and process for preparing the same |
| 02/15/2006 | CN1733098A Heat and toxin clearing oral liquid and preparation process thereof |
| 02/15/2006 | CN1733068A Chinese medicinal preparation for promoting blood circulation, dissipating blood stasis, inducing reuscitation with aromatics and preparation process thereof |
| 02/15/2006 | CN1733061A Chinese medicinal preparation with astragalus root and erigeron breviscapus and application thereof |
| 02/15/2006 | CN1733060A Usage of asiabell and astragalus root composition in decrease of platelet aggregation |
| 02/15/2006 | CN1733059A Cardiovascular and cerebrovascular disease treating medicine |
| 02/15/2006 | CN1733039A Compound preparation of breviscapinum for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 02/15/2006 | CN1732988A Capsule with dried human placemta and red sage root and its preparing process |
| 02/15/2006 | CN1732976A Hemostatic wound healing Dan |
| 02/15/2006 | CN1732972A Dextran for injection and method for preparing the same |
| 02/15/2006 | CN1732970A Breviscapine injection liquid and its preparing process |
| 02/15/2006 | CN1732961A Gallotannins and ellagitannins as regulators of cytokine release |
| 02/15/2006 | CN1732954A Freeze dry emulsion of prostaglandin for injection and method for preparing the same |
| 02/15/2006 | CN1732946A Pharmaceutical composition for preventing and treating poultry ascites |
| 02/15/2006 | CN1732941A Compound medicine for treating meat chicken ascites |
| 02/15/2006 | CN1732925A Sustained release minipills of lovastatin and its preparation process |
| 02/15/2006 | CN1732915A Tanshinone IIA infusion solution and its preparation method |
| 02/15/2006 | CN1732913A Propylgallate injection liquid with favorable stability and its preparation process |
| 02/15/2006 | CN1241946C Human serum albumins recombined merge protein having hyperplasia stimulation function to multiple cells |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |